Table 3.
REMI Ce and OAA/S score during the procedure.
| T1 | T2 | T3 | T4 | ||
|---|---|---|---|---|---|
| REMI Ce | Group 1 | 0 ± 0 | 1.44 ± 0.25 | 1.70 ± 0.33 | 1.70 ± 0.33 |
| Group 2 | 0 ± 0 | 1.89 ± 0.21† | 1.91 ± 0.25* | 1.91 ± 0.25* | |
| OAA/S score | Group 1 | 5 (5–5) | 3 (2–3) | 3 (2–3) | 3 (2–3) |
| Group 2 | 5 (5–5) | 3 (2–4) | 3 (2–4) | 3 (2–4) |
Data are shown as mean ± SD. Group 1: initial REMI Ce of 1.0 ng/mL; Group 2: initial REMI Ce of 2.0 ng/mL.
Ce = effect-site concentration, OAA/S = observer assessment of alertness/sedation, REMI = remifentanil, SD = standard deviation, T1 = before anesthesia induction, T2 = time of the probe insertion, T3 = time of the needle biopsy, T4 = time of the end of procedure.
P < .05 compared with Group 1 at each time point measurement.
P < .001 compared with Group 1 at each time point measurement.